Delivery Order SPE2DB20D2014-SPE2DB25FB41W
Award Date
3/24/25
Potential Completion Date
3/25/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,476.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, a pediatric vaccine, with an ultimate completion date of April 3, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which is valued at...
This federal contract award, valued at $1,895.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, a vaccine product. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $2,231.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, a vaccine product, with an ultimate completion date of February 12, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $7,722.90, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, a medical product used for infectious disease prevention. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,159,821 units of the PEDVAXHIB vaccine in 0.5 mL vials. The contract has a firm fixed price of $3,504.60 and a completion date of February 14, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PEDVAXHIB VACCINE VIAL 0.5ML, with a ceiling value of $1,895.90 and a period of performance through May 13, 2025. The contract is not set aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,858.33, is for the procurement of PEDVAXHIB VACCINE VIAL 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period ending on May 28, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNY92, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,014.73, is for the delivery of the PEDVAXHIB VACCINE VIAL 0.5ML medical product. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.46 firm-fixed-price delivery order is for the PEDVAXHIB vaccine vial (0.5 mL) and has an ultimate completion date of August 7, 2023. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PEDVAXHIB vaccine vials. The contract has a ceiling value of $7,583.60 and a period of performance through June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical division, which provides a...